• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 mRNA 疫苗在孕妇、哺乳期妇女和非孕妇中诱导出不同的抗体 Fc 功能特征。

COVID-19 mRNA vaccines drive differential antibody Fc-functional profiles in pregnant, lactating, and nonpregnant women.

机构信息

Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.

PhD Program in Virology, Division of Medical Sciences, Harvard University, Boston, MA 02115, USA.

出版信息

Sci Transl Med. 2021 Oct 27;13(617):eabi8631. doi: 10.1126/scitranslmed.abi8631.

DOI:10.1126/scitranslmed.abi8631
PMID:34664972
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9067624/
Abstract

Substantial immunological changes occur throughout pregnancy to render the mother immunologically tolerant to the fetus and allow fetal growth. However, additional local and systemic immunological adaptations also occur, allowing the maternal immune system to continue to protect the dyad against pathogens both during pregnancy and after birth through lactation. This fine balance of tolerance and immunity, along with physiological and hormonal changes, contributes to increased susceptibility to particular infections in pregnancy, including more severe coronavirus disease 2019 (COVID-19). Whether these changes also make pregnant women less responsive to vaccination or induce altered immune responses to vaccination remains incompletely understood. To define potential changes in vaccine response during pregnancy and lactation, we undertook deep sequencing of the humoral vaccine response in a group of pregnant and lactating women and nonpregnant age-matched controls. Vaccine-specific titers were comparable between pregnant women, lactating women, and nonpregnant controls. However, Fc receptor (FcR) binding and antibody effector functions were induced with delayed kinetics in both pregnant and lactating women compared with nonpregnant women after the first vaccine dose, which normalized after the second dose. Vaccine boosting resulted in high FcR-binding titers in breastmilk. These data suggest that pregnancy promotes resistance to generating proinflammatory antibodies and indicates that there is a critical need to follow prime-boost timelines in this vulnerable population to ensure full immunity is attained.

摘要

在整个怀孕期间,大量的免疫变化会使母亲对胎儿产生免疫耐受,并允许胎儿生长。然而,还会发生额外的局部和全身免疫适应性变化,使母体免疫系统能够继续通过哺乳保护母婴对病原体的双重保护。这种耐受和免疫的微妙平衡,以及生理和激素变化,导致孕妇在怀孕期间对某些感染的易感性增加,包括更严重的 2019 年冠状病毒病(COVID-19)。这些变化是否也使孕妇对疫苗的反应性降低,或者诱导对疫苗接种的免疫反应改变,目前仍不完全清楚。为了确定怀孕期间和哺乳期疫苗反应的潜在变化,我们对一组孕妇、哺乳期妇女和非孕妇年龄匹配的对照组进行了体液疫苗反应的深度测序。孕妇、哺乳期妇女和非孕妇对照组之间的疫苗特异性滴度相当。然而,与非孕妇相比,在第一剂疫苗后,孕妇和哺乳期妇女的 Fc 受体(FcR)结合和抗体效应功能的诱导呈现出延迟的动力学,在第二剂疫苗后恢复正常。疫苗加强接种可使母乳中产生高 FcR 结合滴度。这些数据表明,妊娠会导致产生促炎抗体的能力下降,并表明在这个脆弱的人群中,需要按照疫苗接种的时间安排进行接种,以确保获得完全的免疫力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/9067624/f2b0219b8303/nihms-1758174-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/9067624/03f4cd0be0af/nihms-1758174-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/9067624/2e9bea342f32/nihms-1758174-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/9067624/a1d0a5940859/nihms-1758174-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/9067624/f2b0219b8303/nihms-1758174-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/9067624/03f4cd0be0af/nihms-1758174-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/9067624/2e9bea342f32/nihms-1758174-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/9067624/a1d0a5940859/nihms-1758174-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/9067624/f2b0219b8303/nihms-1758174-f0004.jpg

相似文献

1
COVID-19 mRNA vaccines drive differential antibody Fc-functional profiles in pregnant, lactating, and nonpregnant women.COVID-19 mRNA 疫苗在孕妇、哺乳期妇女和非孕妇中诱导出不同的抗体 Fc 功能特征。
Sci Transl Med. 2021 Oct 27;13(617):eabi8631. doi: 10.1126/scitranslmed.abi8631.
2
COVID-19 mRNA vaccines drive differential Fc-functional profiles in pregnant, lactating, and non-pregnant women.新冠病毒信使核糖核酸疫苗在孕妇、哺乳期妇女和非孕妇中引发不同的Fc功能谱。
bioRxiv. 2021 Apr 5:2021.04.04.438404. doi: 10.1101/2021.04.04.438404.
3
COVID-19 booster dose induces robust antibody response in pregnant, lactating, and nonpregnant women.COVID-19 加强针在孕妇、哺乳期妇女和非孕妇中均能诱导强烈的抗体反应。
Am J Obstet Gynecol. 2023 Jan;228(1):68.e1-68.e12. doi: 10.1016/j.ajog.2022.07.014. Epub 2022 Jul 19.
4
Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women.COVID-19 mRNA 疫苗在孕妇和哺乳期妇女中的免疫原性。
JAMA. 2021 Jun 15;325(23):2370-2380. doi: 10.1001/jama.2021.7563.
5
Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity.杂合免疫改变了 SARS-CoV-2 mRNA 疫苗诱导免疫的 Fc 效应子质量。
mBio. 2022 Oct 26;13(5):e0164722. doi: 10.1128/mbio.01647-22. Epub 2022 Aug 24.
6
Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study.2019年冠状病毒病疫苗在孕妇和哺乳期妇女中的反应:一项队列研究。
Am J Obstet Gynecol. 2021 Sep;225(3):303.e1-303.e17. doi: 10.1016/j.ajog.2021.03.023. Epub 2021 Mar 26.
7
Longitudinal antibody response kinetics following SARS-CoV-2 messenger RNA vaccination in pregnant and nonpregnant persons.SARS-CoV-2 信使 RNA 疫苗接种后孕妇和非孕妇的纵向抗体反应动力学。
Am J Obstet Gynecol MFM. 2023 Feb;5(2):100796. doi: 10.1016/j.ajogmf.2022.100796. Epub 2022 Nov 2.
8
Preserved recognition of Omicron spike following COVID-19 messenger RNA vaccination in pregnancy.孕妇接种 COVID-19 mRNA 疫苗后对奥密克戎刺突的保留识别。
Am J Obstet Gynecol. 2022 Sep;227(3):493.e1-493.e7. doi: 10.1016/j.ajog.2022.04.009. Epub 2022 Apr 14.
9
Evaluation of immunogenicity and reactogenicity of COVID-19 vaccines in pregnant women.评估 COVID-19 疫苗在孕妇中的免疫原性和反应原性。
Ultrasound Obstet Gynecol. 2022 Nov;60(5):673-680. doi: 10.1002/uog.26050.
10
COVID-19 vaccination in pregnant and lactating diabetic women.COVID-19 疫苗接种在妊娠和哺乳期糖尿病妇女中的应用。
Nutr Metab Cardiovasc Dis. 2021 Jun 30;31(7):2151-2155. doi: 10.1016/j.numecd.2021.04.012. Epub 2021 Apr 24.

引用本文的文献

1
Evaluation of immune responses to Tdap booster during pregnancy in women who received whole cell or acellular pertussis vaccines during childhood.对童年时期接种过全细胞或无细胞百日咳疫苗的孕妇在孕期接种破伤风类毒素、白喉和无细胞百日咳联合疫苗(Tdap)加强针后的免疫反应评估。
Emerg Microbes Infect. 2025 Dec;14(1):2547732. doi: 10.1080/22221751.2025.2547732. Epub 2025 Sep 15.
2
Pregnancy reduces COVID-19 vaccine immunity against novel variants.怀孕会降低新冠疫苗对新型变体的免疫力。
NPJ Vaccines. 2025 Aug 13;10(1):191. doi: 10.1038/s41541-025-01236-4.
3
Patterns and functional consequences of antibody speciation in maternal-fetal transfer of coronavirus-specific humoral immunity.

本文引用的文献

1
Maternal SARS-CoV-2 infection elicits sexually dimorphic placental immune responses.母体感染 SARS-CoV-2 会引起有性二态性胎盘免疫反应。
Sci Transl Med. 2021 Oct 27;13(617):eabi7428. doi: 10.1126/scitranslmed.abi7428.
2
Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women.COVID-19 mRNA 疫苗在孕妇和哺乳期妇女中的免疫原性。
JAMA. 2021 Jun 15;325(23):2370-2380. doi: 10.1001/jama.2021.7563.
3
Cord blood antibodies following maternal coronavirus disease 2019 vaccination during pregnancy.孕期母亲接种2019冠状病毒病疫苗后的脐血抗体
冠状病毒特异性体液免疫母胎转移中抗体种类形成的模式及功能后果。
PLoS Pathog. 2025 Aug 6;21(8):e1013408. doi: 10.1371/journal.ppat.1013408. eCollection 2025 Aug.
4
Pregnancy and lactation induce distinct immune responses to COVID-19 booster vaccination and SARS-CoV-2 breakthrough infection.怀孕和哺乳会引发对新冠病毒加强疫苗接种和新冠病毒突破性感染的不同免疫反应。
JCI Insight. 2025 Jul 22;10(14). doi: 10.1172/jci.insight.191930.
5
Cross-Sectional Survey of Views on COVID-19 and Its Vaccines Among Pregnant Women.孕妇对新冠病毒及其疫苗看法的横断面调查
Matern Fetal Med. 2022 Aug 9;5(2):80-87. doi: 10.1097/FM9.0000000000000149. eCollection 2023 Apr.
6
Maternal Vaccination and Neonatal Feeding Strategies Among Polish Women.波兰女性的孕产妇疫苗接种与新生儿喂养策略
Vaccines (Basel). 2025 Mar 31;13(4):376. doi: 10.3390/vaccines13040376.
7
Safety and Efficacy of Vaccination During Lactation: A Comprehensive Review of Vaccines for Maternal and Infant Health Utilizing a Large Language Model Citation Screening System.哺乳期接种疫苗的安全性和有效性:利用大语言模型引文筛选系统对母婴健康疫苗的全面综述
Vaccines (Basel). 2025 Mar 25;13(4):350. doi: 10.3390/vaccines13040350.
8
Dynamic Changes in Antibodies and Proteome in Breast Milk of Mothers Infected with Wild-Type SARS-CoV-2 and Omicron: A Longitudinal Study.感染野生型SARS-CoV-2和奥密克戎的母亲母乳中抗体和蛋白质组的动态变化:一项纵向研究
Nutrients. 2025 Apr 21;17(8):1396. doi: 10.3390/nu17081396.
9
Vaccination in pregnancy to protect the newborn.孕期接种疫苗以保护新生儿。
Nat Rev Immunol. 2025 Apr 23. doi: 10.1038/s41577-025-01162-5.
10
Enhanced placental antibody transfer efficiency with longer interval between maternal respiratory syncytial virus vaccination and birth.在母体接种呼吸道合胞病毒疫苗与分娩之间延长间隔时间可提高胎盘抗体转移效率。
Am J Obstet Gynecol. 2024 Nov 7. doi: 10.1016/j.ajog.2024.10.053.
Am J Obstet Gynecol. 2021 Aug;225(2):192-194. doi: 10.1016/j.ajog.2021.03.035. Epub 2021 Apr 1.
4
Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study.2019年冠状病毒病疫苗在孕妇和哺乳期妇女中的反应:一项队列研究。
Am J Obstet Gynecol. 2021 Sep;225(3):303.e1-303.e17. doi: 10.1016/j.ajog.2021.03.023. Epub 2021 Mar 26.
5
The multifaceted roles of breast milk antibodies.母乳抗体的多效性作用。
Cell. 2021 Mar 18;184(6):1486-1499. doi: 10.1016/j.cell.2021.02.031.
6
Higher severe acute respiratory syndrome coronavirus 2 infection rate in pregnant patients.孕妇的严重急性呼吸综合征冠状病毒 2 感染率更高。
Am J Obstet Gynecol. 2021 Jul;225(1):75.e1-75.e16. doi: 10.1016/j.ajog.2021.02.011. Epub 2021 Feb 16.
7
Involving Pregnant Individuals in Clinical Research on COVID-19 Vaccines.让孕妇参与新冠疫苗的临床研究。
JAMA. 2021 Mar 16;325(11):1041-1042. doi: 10.1001/jama.2021.1865.
8
COVID-19 Vaccination in Pregnant and Lactating Women.孕妇和哺乳期妇女的新冠疫苗接种
JAMA. 2021 Mar 16;325(11):1039-1040. doi: 10.1001/jama.2021.1658.
9
Assessment of Maternal and Neonatal Cord Blood SARS-CoV-2 Antibodies and Placental Transfer Ratios.评估母体和新生儿脐血 SARS-CoV-2 抗体和胎盘转移率。
JAMA Pediatr. 2021 Jun 1;175(6):594-600. doi: 10.1001/jamapediatrics.2021.0038.
10
Inclusion of Pregnant and Lactating Persons in COVID-19 Vaccination Efforts.将孕妇和哺乳期妇女纳入 COVID-19 疫苗接种工作。
Ann Intern Med. 2021 May;174(5):701-702. doi: 10.7326/M21-0173. Epub 2021 Jan 26.